Table 2.

Adjusted Associations of Clinical Trial Enrollment with Baseline Predictors

	Clinical trial experience			Adjusted result
Baseline correlate	Total (n=325)	Yes (n=30, 9.2%)	No (n=295, 90.8%)	OR/HR	P value
End-of-Life discussion	67 (20.6)	2 (6.7)	118 (98.3)	0.18 (0.04–0.83)	0.03
Want doctor to tell life expectancy	70 (21.5)	16 (6.8)	219 (93.2)	0.31 (0.12–0.79)	0.01
Yale Cancer Center	120 (36.9)	21 (31.3)	46 (68.7)	12.26 (1.09–4.84)	<0.0001
Lung cancer	235 (72.3)	3 (4.3)	67 (95.7)	0.17 (0.04–0.72)	0.02

Note: 325 patients had nonmissing data with the four baseline correlates.

HR, hazard ratio; OR, odds ratio.